Drug Injuries

The popular gout medication Uloric recently received a boxed warning from the U.S. Food & Drug Administration (FDA) due to an increased risk of heart-related death. The U.S. Food and Drug Administration announced a medication …

In recent months, pharmaceutical company Pfizer has been facing numerous lawsuits against its prescription drug, Xeljanz. The Xeljanz lawsuits allege that the drug, when taken at a high dosage, poses an increased risk of serious health conditions such as cancer, deep vein thrombosis (DVT), pulmonary embolism (PE), liver damage, and cardiovascular events like heart attack or stroke.

Patients taking Viberzi to treat irritable bowel syndrome may be at risk of suffering from pancreatitis, which could lead to hospitalization or death.

Many patients are at risk of fatal side effects from taking Actemra, despite marketing efforts by its manufacturer that claim otherwise.

The FDA identified that certain type-2 diabetes medications may trigger the onset of a flesh-eating infection known as Fournier’s gangrene.

Valsartan is a blood pressure medication that was recalled due to the presence of a carcinogenic ingredient patients were not aware of until this year.

A medication used to treat relapsing multiple sclerosis, Gilenya, poses a threat to patients as symptoms may worsen if they discontinue use.

Learn more about the recent FDA “Black Box Warning” on popular multiple sclerosis (MS) and B-cell chronic lymphocytic leukemia (B-CLL) drugs that have been linked to arterial dissection and strokes.

Montelukast sodium tablets were voluntarily recalled because they were mixed up with another medication which could cause injury to an unsuspecting patient.